Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
EFFICACY AND SAFETY OF LEVOSIMENDAN IN AN ISCHEMIC CARDIOGENIC SHOCK POPULATION: A 10-YEARS SINGLE CENTRE RETROSPECTIVE STUDY
Anno:
2023
Background: Levosimendan is a Ca²⁺-sensitizer with inodilator action able to improve cardiac contractility without increse oxygen demand. In AHF setting clinical trial and registries showed an improvement in systemic haemodynamics without a decrease in in-hospital mortality. Purpose: evaluate safety and efficacy of Levosimendan in an ischemic CS population. Methods:…
Leggi di più
VIP-AF. Correlation between Voltage and Impedance mapping in Patients affected by Atrial Fibrillation: a further step towards substrate characterization
Anno:
2023
Background. Pulmonary veins isolation (PVI) represents the main strategy for paroxysmal atrial fibrillation (AF) treatment. Due to the poor clinical outcomes of PVI in case of non-paroxysmal AF, significant efforts have been made to develop new ablative strategies to modify the atrial substrate. Up to now, in order to…
Leggi di più
Screening for subclinical atrial fibrillation after embolic stroke of undetermined source: a single centre experience
Anno:
2023
Introduction: Embolic stroke of undetermined source (ESUS) describes a stroke for which no cause has been found, which implicates embolism as a cause of stroke. There are several mechanisms of cryptogenic ischemic stroke including a covert structural cardiac lesion, paroxysmal atrial fibrillation (AF), hypercoagulable state or undiagnosed malignancy. As…
Leggi di più
VOLTAGE CHARACTERIZATION OF ABNORMAL CONDUCTION ZONES IN PATIENTS AFFECTED BY ATRIAL FIBRIALLATION
Anno:
2023
Background. In case of persistent atrial fibrillation (AF), atrial substrate assumes a dominant role in sustaining the arrhythmia. Recent studies prove that low voltage areas (LVA, Voltage Amplitude < 0,5 mV) represent an additional target for ablation of AF patients.  Purpose. The purpose of this study is to analyse…
Leggi di più
Clinical outcomes of left atrial appendage occlusion with conscious sedation without anesthesiologist on site: results from a multicenter retrospective study.
Anno:
2023
Background: left atrial appendage (LAA) occlusion is an important therapeutic option to prevent cardioembolic stroke in patients with atrial fibrillation (AF) with contraindications for oral anticoagulation (OAC). It is usually performed with transesophageal echocardiography (TOE) under general anesthesia (GA). In this retrospective study we present a multicenter experience of…
Leggi di più
RENAL DENERVATION FOR ATRIAL FIBRILLATION IN DRUG-RESISTANT HYPERTENSIVE PATIENTS. AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
Anno:
2023
INTRODUCTION.   This meta-analysis of randomized controlled trials (RCT) was permormed to compare clinical outcomes following renal denervation (RDN) in drug-resistant hypertensive patients with atrial fibrillation (AF).   METHODS   Data collection: We applied the methods recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. We…
Leggi di più
ATRIAL FIBRILLATION ABLATION IN PATIENTS WITH SEVERELY DEPRESSED EJECTION FRACTION. META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
Anno:
2023
Introduction Atrial fibrillation (AF) and severely depressed ejection fraction (SDEF) are two conditions that often coexist. AF increases overall mortality in these patients. The current available guidelines do not provide a clear consensus regarding the best management approach. We conducted this meta-analysis in order to determine if catheter ablation…
Leggi di più
POSTERIOR WALL CHARACTERIZATION IN PATIENTS AFFECTED BY ATRIAL FIBRILLATION
Anno:
2023
Background. Several clinical data in humans demonstrate that atrial fibrillation (AF) dominant frequencies and rotors are mostly localized on the posterior wall (PW), but the correlation among these phenomena and abnormal conduction properties during sinus (SR) and paced rhythm (PR) has never been analyzed. Aims. To provide a characterization…
Leggi di più
Cryoballoon Ablation for Atrial Fibrillation in Octogenarians: a propensity-score matching comparison with a cohort of younger patients
Anno:
2023
Background: Atrial fibrillation (AF) is the most frequent sustained cardiac arrhythmia in adults with a current estimated prevalence between 2-4% in the general population. AF prevalence increases with advancing age and it is estimated that nearly 10% of octogenarians may be affected by this arrhythmia. In terms of safety…
Leggi di più
Functional mapping: a new approach for substrate characterization in patients affected by atrial fibrillation
Anno:
2023
Background. The ongoing challenge is to generate meaningful data during electrophysiological (EP) studies, integrating the knowledge on atrial fibrillation (AF) progression gained by the EP community in the latest years. At the present time there is a lack of EP protocols and none of the most used approaches take in consideration…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram